Press Release – New York, NY – May 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a clinical stage company developing therapies …
Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock
Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Pareteum Corporation (NASDAQ: TEUM), a cloud communications platform company, as it …
Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd
Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager …
Sichenzia Ross Ference LLP Represents Vuzix Corporation in $11,250,000 Registered Direct Offering
Press Release – New York, New York – May 13, 2020 - Sichenzia Ross Ference LLP announced today that it represented Vuzix Corporation (NASDAQ: VUZI) in a registered direct offering of 5,000,000 shares …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement
Press Release – New York, New York – May 7, 2020 - Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common …
Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock
Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 …
